PE20081402A1 - Sales de timo depresores farmaceuticamente aceptables y procesos para su manufactura - Google Patents
Sales de timo depresores farmaceuticamente aceptables y procesos para su manufacturaInfo
- Publication number
- PE20081402A1 PE20081402A1 PE2007001794A PE2007001794A PE20081402A1 PE 20081402 A1 PE20081402 A1 PE 20081402A1 PE 2007001794 A PE2007001794 A PE 2007001794A PE 2007001794 A PE2007001794 A PE 2007001794A PE 20081402 A1 PE20081402 A1 PE 20081402A1
- Authority
- PE
- Peru
- Prior art keywords
- thimo
- depressors
- processes
- manufacturing
- pharmaceutically acceptable
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 108010016626 Dipeptides Proteins 0.000 abstract 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical group [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 238000002441 X-ray diffraction Methods 0.000 abstract 1
- 229910052744 lithium Chemical group 0.000 abstract 1
- 229910003002 lithium salt Inorganic materials 0.000 abstract 1
- 159000000002 lithium salts Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
REFERIDA A UNA SAL DE D-ISOGLUTAMIL-D-TRIPTOFANO (H-D-iGLU-D-Trp-OH O TIMODEPRESOR) DE FORMULA (I), DONDE M ES POTASIO O LITIO, EL CUAL ES UN DIPEPTIDO HEMOREGULADOR SINTETICO. DICHAS SALES SE ENCUENTRAN TAMBIEN EN FORMA CRISTALINA, DONDE LA SAL DE POTASIO DEL COMPUESTO EN FORMA CRISTALINA PRESENTA PICOS EN UN PATRON DE DIFRACCION DE RAYOS X EN POLVO CON VALORES DE 2-THETA: 9,91, 14,84, 15,81, 18,97, 19,76, 24,04, 24,36, 24,82, 25,48, 27,49, 28,42, 30,82, 31,28, 31,69, 32,17, 34,35, 35,81 Y 36,96 Y LA SAL DE LITIO DEL COMPUESTO PRESENTA PICOS DE 13,57, 15,53, 18,71, 20,11, 23,34, 24,1, 25,09, 27,31, 27,72, 28,39, 29,31, 30,19, 31,21, 32,06, 33,62 Y 37,41. TAMBIEN ESTA REFERIDA A UNA COMPOSICION FARMACEUTICA Y A UN PROCEDIMIENTO DE PREPARACION
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002571645A CA2571645A1 (en) | 2006-12-19 | 2006-12-19 | Pharmaceutically acceptable salts of thymodepressin and processes for their manufacture |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20081402A1 true PE20081402A1 (es) | 2008-11-16 |
Family
ID=39535926
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2007001794A PE20081402A1 (es) | 2006-12-19 | 2007-12-14 | Sales de timo depresores farmaceuticamente aceptables y procesos para su manufactura |
PE2012000979A PE20121642A1 (es) | 2006-12-19 | 2007-12-14 | Sales de timo depresores farmaceuticamente aceptables y procesos para su manufactura |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012000979A PE20121642A1 (es) | 2006-12-19 | 2007-12-14 | Sales de timo depresores farmaceuticamente aceptables y procesos para su manufactura |
Country Status (14)
Country | Link |
---|---|
US (2) | US8138221B2 (es) |
EP (1) | EP2121729A4 (es) |
KR (1) | KR20090108034A (es) |
CN (2) | CN101611050B (es) |
AU (1) | AU2007335212B2 (es) |
CA (2) | CA2571645A1 (es) |
CL (1) | CL2007003680A1 (es) |
MX (1) | MX2009006673A (es) |
PE (2) | PE20081402A1 (es) |
RU (1) | RU2536685C2 (es) |
TW (1) | TWI406872B (es) |
UA (1) | UA106580C2 (es) |
UY (1) | UY30798A1 (es) |
WO (1) | WO2008074128A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2579119C (en) | 2007-02-16 | 2013-03-05 | Apotex Technologies Inc. | Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
EP2062909A1 (en) * | 2007-11-21 | 2009-05-27 | SOLVAY (Société Anonyme) | Peptide production and purification process |
RU2634258C1 (ru) * | 2016-11-08 | 2017-10-24 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Наполнитель для капсульного ингалятора |
RU2703991C1 (ru) * | 2019-02-12 | 2019-10-23 | Акционерное общество "Медико-биологический научно-производственный комплекс "Цитомед" (АО "МБНПК "Цитомед") | Способ получения мононатриевой соли изоглутамил-триптофана |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3238118A1 (de) | 1982-10-14 | 1984-04-19 | Verla-Pharm, Arzneimittelfabrik Apotheker H.J. v. Ehrlich GmbH & Co KG, 8132 Tutzing | Verfahren zur herstellung von komplexverbindungen aus aminodicarbonsaeuren, zweiwertigen metallionen und halogenidionen |
AU566747B2 (en) | 1984-01-10 | 1987-10-29 | Mitsui Chemicals, Inc. | Method of separating l-tryptophan |
US5902790A (en) * | 1995-10-03 | 1999-05-11 | Cytran, Inc. | Pharmaceutical angiostatic dipeptide compositions and method of use thereof |
RU2107692C1 (ru) * | 1995-06-07 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
RU2107691C1 (ru) * | 1995-03-02 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
US6103699A (en) * | 1996-06-07 | 2000-08-15 | Immunotech Developments Inc. | Peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
DE19540788A1 (de) * | 1995-11-02 | 1997-05-07 | Degussa | Verwendung von wässrigen L-Tryptophan- und/oder L-Threonin-Salzlösungen |
US5744452A (en) * | 1995-11-28 | 1998-04-28 | Edward T. Wei | γ-L-glutamyl containing immunomodulator compounds and methods therewith |
US5916878A (en) * | 1995-11-28 | 1999-06-29 | Edward T. Wei | γ-glutamyl and β-aspartyl containing immunomodulator compounds and methods therewith |
IL120923A0 (en) | 1997-05-27 | 1997-09-30 | Amylum Nv | A combined process for the production of lysine and its salts and of a further weak acid and a salt thereof |
AU2007280995C1 (en) * | 2006-08-04 | 2013-05-23 | Manus Pharmaceuticals (Canada) Ltd. | Multifunctional bioactive compounds |
CA2569204A1 (en) * | 2006-11-28 | 2008-05-28 | Apotex Technologies Inc. | Crystalline d-isoglutamyl-d-tryptophan and the mono ammonium salt of d-isoglutamyl-d-tryptophan |
-
2006
- 2006-12-19 CA CA002571645A patent/CA2571645A1/en not_active Abandoned
-
2007
- 2007-12-13 TW TW096147768A patent/TWI406872B/zh not_active IP Right Cessation
- 2007-12-13 KR KR1020097014834A patent/KR20090108034A/ko not_active Application Discontinuation
- 2007-12-13 CN CN2007800508835A patent/CN101611050B/zh not_active Expired - Fee Related
- 2007-12-13 WO PCT/CA2007/002235 patent/WO2008074128A1/en active Application Filing
- 2007-12-13 CA CA002673421A patent/CA2673421A1/en not_active Abandoned
- 2007-12-13 RU RU2009127795/04A patent/RU2536685C2/ru not_active IP Right Cessation
- 2007-12-13 MX MX2009006673A patent/MX2009006673A/es active IP Right Grant
- 2007-12-13 EP EP07855517.4A patent/EP2121729A4/en not_active Withdrawn
- 2007-12-13 CN CN201310459336.XA patent/CN103554004A/zh active Pending
- 2007-12-13 US US12/520,337 patent/US8138221B2/en not_active Expired - Fee Related
- 2007-12-13 UA UAA200907340A patent/UA106580C2/uk unknown
- 2007-12-13 AU AU2007335212A patent/AU2007335212B2/en not_active Ceased
- 2007-12-14 UY UY30798A patent/UY30798A1/es not_active Application Discontinuation
- 2007-12-14 PE PE2007001794A patent/PE20081402A1/es not_active Application Discontinuation
- 2007-12-14 PE PE2012000979A patent/PE20121642A1/es not_active Application Discontinuation
- 2007-12-18 CL CL200703680A patent/CL2007003680A1/es unknown
-
2012
- 2012-03-19 US US13/424,343 patent/US8735602B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2121729A1 (en) | 2009-11-25 |
AU2007335212B2 (en) | 2013-09-05 |
US8735602B2 (en) | 2014-05-27 |
US20100056803A1 (en) | 2010-03-04 |
PE20121642A1 (es) | 2012-12-16 |
WO2008074128A1 (en) | 2008-06-26 |
MX2009006673A (es) | 2009-11-02 |
AU2007335212A1 (en) | 2008-06-26 |
CA2571645A1 (en) | 2008-06-19 |
UA106580C2 (uk) | 2014-09-25 |
KR20090108034A (ko) | 2009-10-14 |
EP2121729A4 (en) | 2013-07-31 |
RU2009127795A (ru) | 2011-01-27 |
RU2536685C2 (ru) | 2014-12-27 |
CN101611050B (zh) | 2013-10-30 |
US8138221B2 (en) | 2012-03-20 |
TWI406872B (zh) | 2013-09-01 |
CN101611050A (zh) | 2009-12-23 |
CA2673421A1 (en) | 2008-06-26 |
TW200833708A (en) | 2008-08-16 |
CL2007003680A1 (es) | 2008-03-14 |
UY30798A1 (es) | 2008-07-03 |
US20130072692A1 (en) | 2013-03-21 |
CN103554004A (zh) | 2014-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1126116T1 (el) | Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη | |
AR112669A2 (es) | Compuestos inhibidores del cotransportador de sodio y glucosa 2 y compuestos útiles para su preparación | |
AR114946A2 (es) | Formas cristalinas de 3-(2,6-dicloro-3,5-dimetoxi-fenil)-1-{6-[4-(4-etil-piperazin-1-il)-fenil-amino]-pirimidin-4-il}-1-metil-urea y sales de las mismas | |
RU2013109393A (ru) | Безилатная соль ингибитора втк | |
PE20050761A1 (es) | Polimorfo cristalino de una sal de bisulfato como antagonista del receptor de trombina | |
AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
PE20110388A1 (es) | Formas cristalinas de un derivado de peptido como inhibidores de hcv | |
JP2006298933A5 (es) | ||
BRPI0923217A2 (pt) | processos para a preparação de um composto de piridona, e para a preparação de uma forma cristalina, composto, sal ou um hidrato deste, forma cristalina de um sal de sódio ou um hidrato deste, e, composição farmacêutica. | |
EA201001669A1 (ru) | Замещенные пиримидин-5-карбоксамиды 281 | |
AR063347A1 (es) | Formas cristalinas de docetaxel y proceso para su preparacion | |
CO5611107A2 (es) | Sales de valsartan | |
MY151295A (en) | Pyrimidyl indoline compound | |
WO2009083940A3 (en) | Processes for the preparation of 2,5-dihydroxybenzenesulfonic acid salts | |
PE20081402A1 (es) | Sales de timo depresores farmaceuticamente aceptables y procesos para su manufactura | |
EA201600088A1 (ru) | Парентеральное введение тапентадола | |
WO2008116601A3 (en) | Solid dosage forms comprising aliskiren and pharmaceutically acceptable salts thereof | |
CO6241155A2 (es) | [4-(6-fluoro-7-metilamina-2,4-dioxo-1,4-dihidro-2hquinazolina-3-ilo)-fenilo]-5-cloro-tiofeno-2-ilo-sales de sulfonilurea y las formas y metodos relacionados con el mismo | |
AR083100A1 (es) | Monohidrato de derivados de aza-adamantano | |
UA89905C2 (ru) | α КРИСТАЛЛИЧЕСКАЯ ФОРМА АРГИНИНОВОЙ СОЛИ ПЕРИНДОПРИЛА, СПОСОБ ЕЕ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ ЕЕ СОДЕРЖИТ | |
MY161749A (en) | Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use | |
AR084862A1 (es) | Formas solidas de inhibidor de girasa (r) 1-etil-3-[5-[2-(1-hidroxi-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzimidazol-2-il]urea | |
AR075418A1 (es) | Polimorfo cristalino de 3-{[5-(azetidin-1-ilcarbonil)pirazin-2-il]oxi}-5-{[(1s)-1-metil-2-(metiloxi)etil]oxi}-n-(5-metilpirazin-2-il)benzamida,composiciones farmaceuticas que los contienen, proceso para prepararla y uso de las mismas para el tratamiento de la diabetes tipo ii y/u obesidad. | |
SA519401614B1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
ECSP10010576A (es) | Formulaciones orales e inyectables de compuestos de tetraciclina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |